Implications of sentinal node mapping on adjuvant therapy (trials) in stage II-III malignant melanoma

  • Lex Eggermont (Speaker)

Activity: Talk or presentation › Oral presentation › Academic

Period2000
Event titleESO proceedings: advanced course in melanoma
Event typeOther

Research programs

  • EMC MM-03-47-11